ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,318,000 | +13.7% | 45,695 | +25.4% | 0.00% | +100.0% |
Q3 2016 | $1,159,000 | +1.0% | 36,436 | +3.0% | 0.00% | 0.0% |
Q2 2016 | $1,148,000 | -86.0% | 35,369 | -88.0% | 0.00% | -90.9% |
Q1 2016 | $8,219,000 | -18.2% | 293,964 | +4.3% | 0.01% | -15.4% |
Q4 2015 | $10,048,000 | +8.4% | 281,840 | +0.5% | 0.01% | 0.0% |
Q3 2015 | $9,270,000 | -22.0% | 280,325 | -1.2% | 0.01% | -13.3% |
Q2 2015 | $11,881,000 | +65.9% | 283,682 | +29.1% | 0.02% | +66.7% |
Q1 2015 | $7,160,000 | +4.1% | 219,708 | +1.4% | 0.01% | 0.0% |
Q4 2014 | $6,881,000 | +27.2% | 216,723 | -0.8% | 0.01% | +12.5% |
Q3 2014 | $5,410,000 | -2.9% | 218,506 | -11.4% | 0.01% | +14.3% |
Q2 2014 | $5,572,000 | +6.1% | 246,650 | +14.3% | 0.01% | -12.5% |
Q1 2014 | $5,251,000 | +7.7% | 215,810 | +10.6% | 0.01% | +14.3% |
Q4 2013 | $4,875,000 | -11.3% | 195,083 | -2.5% | 0.01% | -22.2% |
Q3 2013 | $5,496,000 | +60.7% | 200,075 | +6.1% | 0.01% | +50.0% |
Q2 2013 | $3,421,000 | – | 188,486 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |